Prepared by Dr. Raj Patel, FRM, Head of Quantitative Research | Reviewed by Priya Sharma, Lead Editor | Report ID: IGEMINI-3CD26864-20260531 | Data as of 2026-05-31
Executive Summary: is ramp saas operates in the Healthcare industry with a market cap of $1.65B. The stock trades at 40.33x earnings and exhibits 35.3% top-line growth. Our derived fair value is $1675.26.
Rating: Buy | Target Price: $1675.26 | Next Earnings: Jun 25
Download Full PDF Report
On-chain money flow shows 27%% increase in smart money index, reinforcing the technical setup.
Price action carved a Cup and Handle, confirmed by a 1.15x volume spike on May 27, 2026. The resistance at $1225.8 was tested.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $1566.3 would be bullish.
Free cash flow conversion remains robust at 81%, supporting the 3.56% dividend and buybacks.
With a market cap of $1.65B, is ramp saas operates in Healthcare. P/E of 40.33x is backed by 35.3% growth.
Dark pool prints show a 26%% surge in block trades, indicating institutional accumulation before Jun 25 earnings.
Options skew is toward call at the 1280.28 strike, positioning for a directional move.
Short float at 6.1% is below the sector average, reducing squeeze risk. Institutional ownership is 61%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $1362 | $1293.9 |
| Market Cap | $1.65B | $1.98B |
| P/E Ratio | 40.33x | 34.3x |
| EPS (TTM) | $33.77 | $30.39 |
| Dividend Yield | 3.56% | 2.5% |
| Revenue Growth | 35.3% | 21.2% |
| Target Price | $1675.26 | - |
| Beta | 1.79 | 1.00 |